Beam Therapeutics Inc. (BEAM)
25.33
-0.58 (-2.24%)
At close: Jan 28, 2025, 2:51 PM
Ratios (Annual)
Discover comprehensive ratio statement breakdowns that reveal insights into revenue, expenses, and beyond.
| Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 |
| PE Ratio | -15.85 | -10.39 | -14.99 | -14.88 | -12.27 | -5.72 | -30.35 |
| PS Ratio | 5.56 | 44.95 | 98.73 | 158.97K | 53.48K | n/a | n/a |
| PB Ratio | 2.14 | 3.73 | 6.19 | 15.54 | 9.54 | 4.92 | -58.06 |
| P/FCF Ratio | -11.48 | -103.63 | -45.26 | -34.04 | -11.39 | -19.71 | -79.55 |
| P/OCF Ratio | -14.08 | 121.56 | -77.24 | -39.85 | -13.37 | -32.46 | -89.72 |
| OCF/S Ratio | -0.39 | 0.37 | -1.28 | -3.99K | -4.00K | n/a | n/a |
| Debt / Equity Ratio | 0.18 | 0.24 | 0.17 | 0.41 | 0.25 | n/a | -0.24 |
| Quick Ratio | 5.89 | 4.89 | 7.37 | 3.01 | 3.24 | 5.79 | 0.31 |
| Current Ratio | 5.89 | 4.89 | 4.52 | 3.01 | 3.24 | 5.79 | 0.31 |
| Asset Turnover | 0.26 | 0.05 | 0.04 | 0.00 | 0.00 | n/a | n/a |
| Interest Coverage | n/a | -22.13 | -43.61K | -84.67 | -401.89 | n/a | n/a |
| Return on Equity (ROE) | -0.14 | -0.36 | -0.41 | -1.04 | -0.78 | -0.86 | 1.91 |
| Return on Assets (ROA) | -0.09 | -0.2 | -0.23 | -0.57 | -0.5 | -0.69 | -3.33 |
| Return on Capital (ROIC) | -0.14 | -0.3 | -0.31 | -0.38 | -0.59 | -0.32 | 1.89 |
| Dividend Yield | n/a | n/a | n/a | n/a | 0.01 | n/a | n/a |
| Payout Ratio | n/a | n/a | n/a | n/a | -0.16 | n/a | n/a |
| Gross Profit Margin | -15.8% | 62.94% | 68.29% | -429.81K% | -29.94K% | n/a | n/a |
| Net Profit Margin | -35.09% | -432.68% | -658.44% | -1.07M% | -435.79K% | n/a | n/a |
| Pretax Profit Margin | -34.73% | -427.08% | -714.91% | -810.80K% | -435.14K% | n/a | n/a |
| Operating Profit Margin | -46.73% | -555.61% | -757.01% | -553.17K% | -417.52K% | n/a | n/a |
| FCF Margin | -48.43% | -43.37% | -218.11% | -467.07K% | -469.56K% | n/a | n/a |
| EBITDA Margin | -41.43% | -532.39% | -757.01% | -533.44K% | -398.06K% | n/a | n/a |